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Zusammenfassung: Pharmakologische Untersuchungen der Ausbreitung von spreading 
depression-Reaktionen in der Hirnrinde der Ratte 
Aziza El Harrak 
Als Cortical Spreading Depression (CSD) wird eine zeitlich limitierte Störung der kortikalen 
Ionenhomöostase bezeichnet, die sich langsam und wellengleich über den Neokortex und 
andere Bereiche grauer Substanz ausbreitet und zu einer konsekutiven Unterdrückung der 
neuronalen Aktivität führt. CSD ist ein akut auftretendes Phänomen, das aus verschiedenen 
Interaktionen synaptischer Transmissionen im Kortex resultiert. Die vorliegende 
Untersuchung befasst sich mit den Entstehungsmechanismen der CSD. CSD wurden durch 
eine KCL-Injektion in die dritte Schicht (layer III) des Kortexpräparats induziert. Die 
Aufzeichnung der  Feldpotentiale der CSD erfolgte simultan durch vier Mikroelektroden, die 
mit einem Abstand von 2-3 mm ebenfalls in der dritten Schicht platziert wurden. Ziel der 
Arbeit war es den Einfluss verschiedener Substanzen auf die CSD und ihre Ausbreitung zu 
untersuchen. Dabei wurden folgende Substanzen verwendet: NMDA receptor antagonist DL-
2-Amino-5-phosphonovaleric acid (APV), AMPA receptor antagonist 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX), GABA receptor antagonist bicuculline, dopamine D1 
receptor agonist SKF 81297, und dopamine D2 receptor agonist quinpirole. Die 
elektrodennahe Zugabe von APV führte zu einer signifikanten Reduktion der 
Ausbreitungsgeschwindigkeit und der CSD-Amplitude. Die fokale Zugabe der anderen 
Substanzen zeigte weder eine Wirkung auf die  Ausbreitungsgeschwindigkeit noch auf die 
Amplitude. Die Ergebnisse dieser Untersuchung weisen auf eine Beteiligung des Glutamat 
NMDA Subrezeptors APV bei der Entstehung der CSD im somatosensorischen Kortex der 
Ratte hin. 
Tag der müdlichen Prüfung: 20.11.2009 
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Abstract 
Cortical spreading depression (CSD) is a massive but temporary perturbation in the cortical 
ionic homeostasis leading to a depression of neuronal activity that spreads (hence the name) 
through the neocortex and other gray matter regions in the brain. CSD is an emergent 
phenomenon arising from the interaction of many different transmission phenomena in the 
cortex. In this study, the basic pharmacological mechanisms of the propagation of CSD in rat 
neocortical tissues were investigated. CSD were induced by injection of KCl in the third 
layers of neocortical tissues. Simultaneous field potential recordings of CSD were obtained 
from four microelectrodes placed 2-3 mm apart across coronal slices in the third layer of the 
neocortex. The effects of NMDA receptor antagonist DL-2-Amino-5-phosphonovaleric acid 
(APV), AMPA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), GABA 
receptor antagonist bicuculline, dopamine D1 receptor agonist SKF 81297, and dopamine D2 
receptor agonist quinpirole on lateral propagation of CSD were investigated. APV, applied 
focally between recording sites, significantly reduced CSD propagation velocity across treated 
areas as well as the amplitude of CSD. Focal application of other substances did not change 
the characteristics of CSD and its horizontal propagation. These results indicate the 
importance of glutamate NMDA subreceptors in propagation of CSD in rat somatosensory 
neocortex. 
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Introduction 
 
Spreading depression (SD) is a phenomenon which represents as a propagating wave of 
neuronal depolarisation followed by a transient wake of depression (Leao, 1944; Gorji, 2001). 
SD could be initiated by different stimuli in animal models and studied in various in vivo and 
in vitro experimental models. It was first induced by applying a brief tetanus of faradic 
stimulation to the rabbit cortex (Leao, 1944; Bures et al., 1974). Mechanical stimulation, for 
example, by stroking of the cortical surface with a blunt instrument, a falling weight or even 
lightly tapping the cortex also initiates SD (Lea˜o, 1944). More recent studies have achieved 
more reliable and reproducible induction of SD by rapidly inserting and retracting 
hypodermic steel needles (Lambert et al., 1999; Ebersberger et al., 2001). However, the most 
common models of SD initiation is KCl application (Wernsmann et al., 2006; Dehbandi et al., 
2008). This model has been shown to be the most reliable stimulus leading to reproducible 
events on earlier occasions in both non-imaging and imaging studies (Bradley et al., 2001). In 
any case, changes in extracellular K+ concentration themselves might be involved in such 
pathophysiological processes in human brain tissue (Mayevsky et al., 1996; Nicholson and 
Sykova, 1998). SD appears to affect both the neuronal and the glial cells. 
 The first paper on SD, titled "Spreading depression of activity in the cerebral cortex" 
appeared in 1944, written by a Brazilian neuroscientist, Aristides Leão, working at the 
Harvard laboratory. Leão wanted to study the electrocorticogram (ECoG) of experimental 
epilepsy in anesthetized rabbits, but he was distracted from his original goal by an unexpected 
flattening of the ongoing normal bioelectrical activity that took the place of the anticipated 
epileptiform field potentials. The silencing of the ECoG trace crept slowly over the cortex, 
from one recording electrode pair resting on the cortical surface to the one beside it. 
According to Leão, SD and propagating focal seizures were related phenomena, generated by 
the same cellular elements, an inference later supported by others. 
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SD is an "all-or-none" type process and propagates in the manner of a wave through gray 
matter. SD appears first at the stimulated site and spreads out in all directions at the velocity 
of 2–3 mm/min, so that increasingly distant areas undergo successively a similar temporary 
depression. A crucial manifestation of SD is a propagating negative potential with amplitude 
of 10–30 mV and duration of more than 30 sec, which may be preceded or succeeded by a 
positive fluctuation of variable amplitude and duration (Figure 1). Underlying this cellular 
depolarisation is a dramatic change in the distribution of micromilieu ions between extra- and 
intracellular compartments. Potassium and proton release from the cells, while sodium, 
calcium and chloride enter together with water causing cells to swell and the volume of the 
extracellular compartment to be decreased. SD is accompanied by an increase of glucose 
utilization and O2 consumption. Recovery of SD depends on energy metabolism. 
SD has been studied in vivo and in vitro in brain slices and in retinal preparations under 
different experimental conditions. It has been also observed in human neocortical tissue in 
vitro and in human hippocampus as well as striatum and neocortex in vivo. SD can be 
regularly initiated if the tissue susceptibility is artificially raised. Hypoxia as well as 
hypoglycemia and changing the extracellular ionic concentrations by administration of 
solutions with increased K+, decreased NaCl or with the Cl− of the latter replaced by certain 
other anions lower the threshold (Gorji, 2001). 
There is sufficient evidence to admit the SD plays an important role in different neurological 
disorders (Gorji, 2001; Somjen, 2001). Subdural recordings in patients demonstrated that SD 
is critically involved in various disorders associated with acute neuronal injury including 
traumatic and spontaneous intracerebral haemorrhage (Strong et al., 2002; Fabricius et al., 
2008) as well as subarachnoid haemorrhage and ischaemic stroke and contribute to tissue 
damage. Furthermore, propagation of a SD-like phenomenon in human neocortical tissues has 
been shown to generate aura symptoms in migrainous patients (Hadjikhani et al. 2001). 
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Although interrelation of SD and epilepsy has been considered for a long time, the possible 
pathophysiological role of SD in epilepsy needs to be elucidated.  
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Figure 1. Vertical propagation of a negative DC-potential wave after injection of KCl in a 
neocortical slice. Injection of KCl solution (3 M) via a microelectrode elicited spreading 
depression-like fluctuation during superfusion with artificial cerebrospinal fluid. Injecting and 
recording electrodes arranged as shown. Voltage variations were recorded simultaneously by 
four electrodes (DC1–DC4) which set apart by 1 mm (Adopted from Gorji et al., 2001). 
SD is also a well-known phenomenon in experimental epilepsy. SD has been observed in a 
variety of in vitro and in vivo epilepsy models in different animal species. Reduction of 
extracellular Mg2+ concentrations, activation of NMDA receptors, blocking of K+ channels, 
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e.g., by 4-aminopyridine, increased extracellular K+, blocking of Na+–K+ ATPase, e.g., by 
ouabain, blocking of Ca2+ channels, e.g., by NiCl2, blocking of GABA receptors, e.g., by 
picrotoxin, are the common pathways for eliciting epileptiform burst discharges and SD in 
experimental models. By all aforementioned mechanisms SD appears spontaneously between 
epileptiform ictal events. SD can be elicited in susceptible area by a single discharge of an 
epileptic focus (spike triggered SD). Epileptiform field potentials usually suppress during SD 
occurrence and reappear in few minutes. CSD penetration into the epileptic foci was 
established in different model of epilepsy. However, it should be noted that SD does not enter 
electrically or pharmacologically elicited foci of epileptic activity with high rates of interictal 
discharges which resulted in anomalous SD propagation. This abnormal SD conduction may 
account for periodic changes of ictal and interictal activity found in some types of focal 
epilepsy. 
Propagation of SD 
Widely accepted hypotheses hold that the primary event responsible for both the initiation and 
the propagation of SD is the release of some substance from neuronal elements to the 
extracellular compartment, which initially excites and then depresses adjacent neurons. The 
slowness of diffusion of the mediator would account for the low velocity of SD propagation. 
Among the substances proposed to mediate SD propagation are potassium (Grafstein, 1963; 
Bures et al., 1974) and excitatory amino acids (Fabricius et al., 1993). There are, however, 
observations that are difficult to reconcile with either of these two propositions. 
SD had been interpreted as a composite process or a sequence of several linked events. To 
solve its genesis, a most important question concerns identification of the very first step in the 
chain reaction. In the extant literature, however, generally more attention has been given to 
the major depolarization and the attending extracellular potential shift (AI’,) than to the 
antecedent events. Among antecedents heralding the onset of SD that have been reported, are 
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a slight increase of extracellular potassium, a small positive shift preceding the fast negative 
shift of the extracellular potential and several types of fast field activity including a short burst 
of action potentials or intense synaptic noise (Leao, 1944; Higashida et al., 1974). Even a 
silence of spontaneous or evoked activity has occasionally been described prior to other signs 
(Higashida et al., 1974). Not all of these early signs are obligatory prodromals of the large, 
accelerating, regenerative depolarization that is typical of the process. 
 
Even though the discharge of impulses is not required for the initiation or the propagation of 
SD, the impulse shower does regularly appear at its beginning. The mechanism that gives rise 
to the impulse discharge may well have a key role in the evolution of SD. The widely spread 
synchronization seems best explained by electrical continuity that could be provided by gap 
junctions. Effective communication by way of quasi-syncytial nets has been demonstrated in 
other systems, for example in the spread of so-called calcium waves in cell cultures (Cornell- 
Bell et al., 1990). Patent gap junctions may provide a path not only for electric current and for 
ions but also for intracellular “second” messengers and other active ingredients in cytosol. SD 
has frequently been interpreted as a diffusion-reaction process whose velocity of spread is 
governed by the rate of the reaction, which could involve the release of some substance from 
cells that then acted on the cell membrane of adjacent cells. As there are reasons for doubting 
a decisive role of either K or of glutamate, we are proposing an alternative hypothesis, 
involving the exchange of chemical signals not through the interstitial space but by way of 
gap junctions. The autocatalytic reaction so initiated would alter the membrane from the 
inside, instead of acting on receptors on the outside. 
Cortical structures are organized to process information in a parallel manner via excitatory 
and inhibitory interactions within and between adjacent cortical modules (Mountcastle, 1997). 
Throughout the CNS, local circuit inhibition plays an integral role in both neuronal network 
processing and the regulation of the excitability of projection neurons. Inhibitory circuits may 
 10
be particularly important to signal processing in cortical networks with pronounced recurrent 
excitatory interactions (Wong et al., 1984). This inhibition may limit the lateral spread of 
excitation and facilitate discharge synchronization of projection neurons by inducing a 
synchronous refractory period. Breakdown in the dynamic balance of inhibitory and 
excitatory interaction can lead to a functional disconnection (Wong and Prince, 1990) and 
disrupts the normal spread of lateral excitation (Grunze et al., 1996). 
Lateral propagation of CSD could be considered as a crucial factor in induction of some 
pathological processes in brain. Therefore, basic pharmacological mechanisms of this 
propagation in rat neocortical tissues were investigated. 
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Material and methods 
 Slice preparation 
Adult rats (250–300 g) were decapitated under deep methohexital anaesthesia and the brains 
were rapidly removed to ice-cold (4 °C) artificial cerebrospinal fluid (ACSF). The cerebellum 
was removed and a cut was made to divide the two cerebral hemispheres. Slices containing 
the temporal cortex, the perirhinal cortex, the entorhinal cortex, the subiculum, the dentate 
gyrus, the hippocampus, as well as the amygdala (500 µm) were cut in a nearly horizontal 
plane. Up to two different slices from each side were collected in a preparation. Slices were 
stored at 28 °C in ACSF, which contained (in mm) NaCl, 124; KCl, 4; CaCl2, 1.0; NaH2PO4, 
1.24; MgSO4, 1.3; NaHCO3, 26; glucose, 10 (pH 7.4), oxygenated with 95% O2 and 5% CO2 
for > 1 h. After 30-min incubation, CaCl2 was elevated to 2.0 mmol/L. Slices were 
individually transferred to an interphase recording chamber, placed on a transparent 
membrane, illuminated from below and continuously perfused (1.5–2 mL/min) with 
carbogenated ACSF at 32 °C. A warmed, humified 95% O2 and 5% CO2 gas mixture was 
directed over the surface of the slices. 
Electrophysiological recordings 
Simultaneous extracellular field potentials were recorded via two glass microelectrodes (150 
mmol/L NaCl; 2 - 10 MΩ) positioned at approximately 5-10 mm intervals across the length of 
the slice in the third cortical layer (figure 2). The reference electrode and the connection to the 
microelectrode were symmetric Ag-Ag-KCl bridges. Field potentials were traced by an ink 
writer and recorded by a digital oscilloscope. Inter-electrode distances were measured with a 
calibrated eyepiece through the microscope. 
Induction of CSD 
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A glass electrode filled with 2 m KCl was fixed in a special holder connected with plastic tube 
to a pressure injector and the tip inserted into the temporal neocortical slices (layer III). A 
high-pressure pulse was applied to inject in the tissue an amount of K+ sufficient to induce 
CSD (tip diameter, 2 µm; injection pressure, 0.5–1.0 bar applied for 200–300 ms, two 
separate injections, 1–3 nL per pulse, 2–5 mm apart from nearby recording electrodes). CSD 
were evaluated with respect to their amplitudes, duration and velocity rates. Duration of DC 
potential fluctuation width was measured at its half-maximal amplitude. 
Experimental procedure 
After minimum 30 min incubation, CSD was induced by KCl application. After another 15 
min, several compounds were applied to small areas of cortex between the two middle 
electrodes of the four-channel array. Compounds applied were: DL-2-Amino-5-
phosphonovaleric acid (APV; 50 μmol/L), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 10 
μmol/L), bicuculline (10 μmol/L), SKF 81297 (25 μmol/L), and quinpirole (20 μmol/L). The 
abovementioned drugs were administered focally through microelectrodes on to slices 
(electrode tip diameter 2–3 μM, 0.5–2 bar; 500–800 ms, 3–5 nl). Drugs were released through 
microelectrodes on to the surface of the slices. A strip of filter paper controlled diffusion of 
the drugs.  
All compounds were purchased from Sigma Chemical Company. All data are given as mean ± 
standard error of the mean (SEM). The data were statistically analyzed using the Mann–
Whitney rank sum test. Multiple comparisons were performed by analysis of variance test 
(ANOVA) for repeated measures followed by a Dunn's test. Significance was established 
when the probability values were <0.05. The experiments were approved by the 
Bezirksregierung Münster (Tierversuchsgenehmigung, Bezirksregierung Münster, 
Deutschland, AZ: 50.0835.1.0, G79/2002). 
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Figure 2. Arrangement of recording and application electrodes. 
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Results 
Control slices 
Application of KCl in to neocortical slices elicited fluctuations of the DC potentials consisting 
of initially negative shifts, followed by positive waves. The triggered wave propagated first 
the nearby electrode, and a few seconds later the other electrode located parallel to this 
electrode. The amplitude and duration of negative DC deflections were 13.6 ± 0.8 mV and 
102 ± 13.1 seconds, respectively, in the first electrode. The amplitude and duration of CSD 
recorded by the second electrode was 11.5 ± 0.6 mV and 93 ± 10.3 seconds, respectively. The 
velocity of SD propagation was determined by dividing the distance between two 
microelectrodes by the interval of DC potential shift appearances. The velocity of vertical 
propagation of DC fluctuation was 3.6 ± 0.2 mm/min.  
Pharmacological investigation of horizontal CSD propagation 
We studied the involvement of the different receptors in horizontal propagation of CSD by 
application of antagonists or agonists of these receptors in the somatosensory neocortical 
slices. The roles of NMDA-subreceptors were tested by local application of NMDA 
antagonist, APV (50 micromol/l, n = 16). Administration of APV significantly decreased the 
velocity of CSD propagation. CSD propagated with the speed of 2.1 ± 0.2 after application of 
APV (P ≤ 0.001; ANOVA test, Holm-Sidak’ method). Furthermore, amplitude of CSD also 
decreased to 7.3 ± 0.4 mV under application of APV (figure 3). After one hour washout of the 
slices with ACSF, CSD induced by another KCl injection. Both velocity and amplitude of 
CSD returned to APV pre-application levels (12.7 ± 0.7 mV and 96 ± 12.7 seconds). 
However, application of AMPA receptor antagonist CNQX (10 μmol/L; n = 12), GABA 
recptor antagonist bicuculline (10 μmol/L; n = 12), dopamine D1 receptor agonist SKF 
 15
81297(25 μmol/L; n = 12), und dopamine D2 receptor agonist quinpirole (20 μmol/L; n = 12) 
did not change the velocity of CSD horizontal propagation. These substances also did not alter 
the amplitude as well as duration of CSD after application of abovementioned drugs. 
F P1
F P2
F P1
F P2
FP1 Fp2
ACSF NMDA
 
Figure 3. Local application of glutamate NMDA sub-receptor antagonist DL-2-Amino-5-
phosphonovaleric acid (APV; 50 μmol/L) decreased the velocity of horizontal propagation of 
CSD as well as the amplitude of CSD in rat somatosensory neocortical tissues. 
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Discussion 
The present data indicate that blocking of glutamate NMDA sub-receptor play an important 
role in horizontal propagation of CSD in rat somatosensory neocortical tissues. However, this 
study revealed that glutamate AMPA sub-receptor as well as GABA and dopamine receptors 
have no effect in lateral propagation of CSD in these tissues. 
SD cellular correlate is a depolarization shift associated with complete breakdown of the 
membrane potential that is dependent on the asymmetric intra- and extracellular ion 
distribution and is maintained by the energy consuming work of membrane pumps. The 
ability of neurons to generate action potentials is lost during SD, which explains the spreading 
electrical silence accompanied SD under physiological conditions (Somjen 2001). In the other 
hand, epileptic activity is characterized by the paroxysmal depolarization shift, a 
hypersynchronous network event resulting from a giant excitatory postsynaptic potential. A 
paroxysmal depolarization shift is the correlate of. The EPSP is presumably the consequence 
of synchronous activation of recurrent excitatory pathways (Jonston and Brown, 1984). SD is 
accompanied by a very large increase in [K+]o. The increase in [K+]o is accompanied by a 
precipitous drop in [Cl ]o, [Na+]o, and [Ca2+]o.  
It was postulated that the excitatory amino acid glutamate plays a role in the chain of events 
triggering SD (Bures et al., 1974). The neocortex releases excitatory amino acids including 
glutamate and aspartate, to the extracellular space during CSD (Van Harreveld and Kooiman, 
1965). Subsequently it has been shown that the triggering of SD requires activation of the 
NMDA subtype of glutamate receptor in rat cerebral cortex (Bures et al., 1974), in chick 
retina (Seeling, 1993) and in human neocortical tissues (Gorji et al., 2001). Other glutamate 
subreceptor (AMPA, kainate and quisqualate) can induce SD but their initiation inhibited by 
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NMDA receptor antagonist (Lauritzen et al., 1988). This suggests that glutamate evokes SD 
via an action at NMDA receptors. 
Migraine sufferers (notably with aura) have substantially higher plasma glutamate and 
aspartate levels than controls and tension headache patients between attacks. During migraine 
attacks, glutamate and to a lesser extent aspartate levels are even further increased which 
show a defective cellular reuptake mechanism for these excitatory amino acids in migraineurs 
(Ferrari et al., 1990). Another study showed that migraine patients during attacks had higher 
CSF concentrations of glutamic acid than in controls (Martinez et al., 1993). Aura symptoms 
cause severe disability over many hours to days in patients with familial hemiplegic migraine 
(FHM). Intranasal application of the NMDA antagonist ketamine reversibly reduced the 
severity and duration of neurological deficit in FHM (Kaube et al., 2000). Subcutaneous 
administration of ketamine produced a marked relief of pain both as an acute treatment and as 
a prophylactic therapy in migraineurs (Nicolodi and Sicuteri, 1995). In addition, it was 
suggested that NMDA-mediated transmission is involved in nociceptive trigeminovascular 
transmission within the trigeminocervical complex in cats (Goadsby and Classey, 2000). The 
NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat 
trigeminal nucleus caudalis suggest that NMDA receptors provide a potential therapeutic 
target for cephalic pain (e.g., migraine) due to trigeminovascular activation from meningeal 
afferents (Mitsikostas et al., 1989).  
5-HT1A receptor stimulation suppresses NMDA receptor-mediated synaptic excitation in the 
rat visual cortex (Edagawa et al., 1999). NMDA receptor blockade as well as activation of the 
5-HT1A receptor attenuates the properties of KCl-induced SD in parietal cortical slices of 
adult rats (Kruger et al., 1999). Migraine patients have a greater cerebral 5-HT1A 
hypersensitivity and several anti-migraine agents exhibit marked 5-HT1A receptor activity 
(Leone et al., 1998). 
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Magnesium is known to block the NMDA receptor. The available evidence suggests that up to 
50% of patients during an acute migraine attack have lowered levels of ionized magnesium 
(Ramadan et al., 1999). Erythrocytes and lymphocytes magnesium concentrations are 
significantly lower in migraine patients as compared to controls (James et al., 2000). Infusion 
of magnesium results in a rapid and sustained relief of an acute migraine in such patients 
(Mauskop et al., 1995). However, it should be mentioned that magnesium concentration has 
an effect on serotonin receptors, nitric oxide synthesis and release, and a variety of other 
migraine-related receptors and neurotransmitters (Mauskop and Altura, 1998). It is well 
known that reduced magnesium facilitates the development of SD in animal models and 
human tissues (Mody et al., 1987). Intravenous magnesium as well as the NMDA receptor 
antagonist MK-801 significantly reduced the frequency of SD evoked by cortical KCl 
application in rats. On the other hand, SD affects magnesium metabolism in the central 
nervous system (van der Hel et al., 1998). The magnesium sulphate anesthesia was 
considerably shortened approximately four times by CSD in functional decorticated mice in 
comparison with control animals (Bohdanecky and Necina 1963). All these data, in line with 
our findings, showed the importance of NMDA receptors in CSD and its related neurological 
disorders. 
Our data revealed that GABA receptors have no effect on CSD lateral propagation. However, 
it should be noted that these receptors are important for CSD initiation. Increasing of 
potassium concentration may further impairs GABA mediated inhibition and leads to 
appearance of ictaform burst discharges. Higashima et al. (1996) have shown that activation 
of GABAergic mechanisms is necessary for the generation of afterdischarges recorded in 
hippocampal slices after electrical stimuli. Experimental and computational data obtained by 
Traub et al. (1996) also suggest a role played by GABAA-mediated depolarizing conductance 
in the epileptiform synchronization that occurs in some models of epileptiform discharge (in 
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particular that induced by 4AP application). GABAergic inhibitory networks can also 
synchronize principal cells in the neocortex and hippocampus (Cobb et al. 1995). Higashima 
et al. (1996) have shown that activation of GABAergic mechanisms is necessary for the 
generation of afterdischarges recorded in hippocampal slices after electrical stimuli. 
Experimental and computational data obtained by Traub et al. (1996) also suggest a role 
played by GABAA-mediated depolarizing conductance in the epileptiform synchronization 
that occurs in some models of epileptiform discharge (in particular that induced by 4AP 
application). GABAergic inhibitory networks can also synchronize principal cells in the 
neocortex and hippocampus (Cobb et al. 1995). 
Conclusion 
The data present electrophysiological evidence for crucial role of NMDA receptors in CSD 
lateral propagation in the somatosensory neocortex of rats. Evidences indicate an importants 
role of NMDA receptors in CSD related neurological disorders such as migraine with aura. 
The clinical impact of these findings will be the subject of future investigations on new 
strategy for treatment of these neurological disorders. 
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